To the Point

Hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, welcome guest Mile Brujic, OD, FAAO, for a lively discussion of the most common conditions that can be mistaken for dry eye disease. Dr. Brujic also reviews the signs and symptoms that can be red flags that something else is occurring with a patient’s ocular or systemic health.

In this month’s episode of To the Point, Jackie Garlich, OD, FAAO, and Cecelia Koetting, OD, FAAO, Dipl ABO, talk about the most exciting, important, and novel ocular surface disease (OSD) news to come out of the past year, including FDA approvals, product launches, new clinical data, and more. They also discuss what developments to watch out for in the OSD space this coming year.

This month on To the Point, learn about meibomian gland probing in patients with dry eye with Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO. Their guest, Rana Taji, OD, MSc, FAAO, explains what it is, how to do it, why to do it, and more.

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, are joined by Sathi Maiti, OD, FAAO, who shares her knowledge and experience working on dry eye clinical research. Dr. Maiti offers great advice on what you need to know before seeking out a clinical trial, how to delegate tasks to your staff related to the study, tips for patient recruiting and scheduling, and other considerations.

Jacob Lang, OD, FAAO, shares his knowledge of innovative therapies for dry eye with Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO. He discusses drugs in development that target pathways involved in ocular surface disease, such as reactive aldehyde species inhibitors, transient receptor potential receptors, and more.